Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity

被引:58
作者
Pigini, M
Bousquet, P
Carotti, A
Dontenwill, M
Giannella, M
Moriconi, R
Piergentili, A
Quaglia, W
Tayebati, SK
Brasili, L
机构
[1] UNIV STRASBOURG 1, FAC MED, CNRS URA 589, PHARMACOL CARDIOVASC & RENALE LAB, F-67000 STRASBOURG, FRANCE
[2] UNIV BARI, DIPARTIMENTO FARMACOCHIM, I-70125 BARI, ITALY
[3] UNIV MODENA, DIPARTIMENTO SCI FARMACEUT, I-41100 MODENA, ITALY
关键词
D O I
10.1016/S0968-0896(97)00009-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The observation that all the attempts to characterize imidazoline (I) receptors have been carried out with non-selective or poorly selective ligands prompted us to undertake research aimed at developing selective ligand(s). In previous work using, as a starting point, cirazoline 1, a potent alpha(1)-adrenergic receptor agonist that also binds to I receptors, we showed that removal of the cyclopropyl ring (2) retains high affinity for I-2 receptors while reducing alpha(1)-adrenergic agonist activity. However, it was felt that this residual, albeit modest, alpha(1)-adrenergic agonist activity might diminish the usefulness of compound 2, and we now report on our continuing efforts in this field. Starting from compound 2, we first eliminated the alpha(1)-agonist component by isosteric replacement and then, by means of conformational restrictions on compound 7, succeeded in discovering tracizoline (9) and benazoline (12). These two new ligands with high affinity (pK(i) value 8.74 and 9.07, respectively) and unprecedented selectivity with respect to both alpha(2)-(I-2/alpha(2) 7,762 and 18,621) and alpha(1)-(I-2/alpha(1) 2,344 and 2,691) adrenergic receptors, are valuable tools in the study of I receptor structure and function. In addition, the large number of derivatives studied has allowed us to establish congruent qualitative structure-activity relationships and identify some structural elements governing affinity and selectivity. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:833 / 841
页数:9
相关论文
共 56 条
[1]  
BLACK MH, Patent No. 1647
[2]  
BOUSQUET P, 1984, J PHARMACOL EXP THER, V230, P232
[3]   SEPARATION OF ALPHA-ADRENERGIC AND IMIDAZOLINE/GUANIDINIUM RECEPTIVE SITES (IGRS) ACTIVITY IN A SERIES OF IMIDAZOLINE ANALOGS OF CIRAZOLINE [J].
BRASILI, L ;
PIGINI, M ;
MARUCCI, G ;
QUAGLIA, W ;
MALMUSI, L ;
LANIER, SM ;
LANIER, B .
BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (11) :1503-1509
[4]   THE IMIDAZOLINE PREFERRING RECEPTOR - BINDING-STUDIES IN BOVINE, RAT AND HUMAN BRAIN-STEM [J].
BRICCA, G ;
DONTENWILL, M ;
MOLINES, A ;
FELDMAN, J ;
BELCOURT, A ;
BOUSQUET, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (01) :1-9
[5]   HUMAN BRAIN IMIDAZOLINE RECEPTORS - FURTHER CHARACTERIZATION WITH [H-3] CLONIDINE [J].
BRICCA, G ;
GRENEY, H ;
ZHANG, JS ;
DONTENWILL, M ;
STUTZMANN, J ;
BELCOURT, A ;
BOUSQUET, P .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 266 (01) :25-33
[6]  
CARPENE C, 1995, J PHARMACOL EXP THER, V272, P681
[7]   THE IMIDAZOLINE SITE INVOLVED IN CONTROL OF INSULIN-SECRETION - CHARACTERISTICS THAT DISTINGUISH IT FROM I-1-SITE AND I-2-SITE [J].
CHAN, SLF ;
BROWN, CA ;
SCARPELLO, KE ;
MORGAN, NG .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (04) :1065-1070
[8]   ALPHA-ADRENORECEPTOR REAGENTS .2. EFFECTS OF MODIFICATION OF THE 1,4-BENZODIOXAN RING-SYSTEM ON ALPHA-ADRENORECEPTOR ACTIVITY [J].
CHAPLEO, CB ;
MYERS, PL ;
BUTLER, RCM ;
DAVIS, JA ;
DOXEY, JC ;
HIGGINS, SD ;
MYERS, M ;
ROACH, AG ;
SMITH, CFC ;
STILLINGS, MR ;
WELBOURN, AP .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (05) :570-576
[9]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[10]  
COZZI P, Patent No. 3830419